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The large Maf transcription factors, MafA and MafB,
are expressed with distinct spatial–temporal patterns
in rodent islet cells. Analysis of Mafa2/2 and pancreas-
speciﬁc MafaΔpanc deletion mutant mice demon-
strated a primary role for MafA in adult b-cell activity,
different from the embryonic importance of MafB. Our
interests here were to precisely deﬁne when MafA be-
came functionally signiﬁcant to b-cells, to determine
how this was affected by the brief period of postnatal
MafB production, and to identify genes regulated by
MafA during this period. We found that islet cell orga-
nization, b-cell mass, and b-cell function were inﬂu-
enced by 3 weeks of age in MafaDpanc mice and
compromised earlier in MafaDpanc;Mafb+/2 mice.
A combination of genome-wide microarray proﬁling,
electron microscopy, and metabolic assays were used
to reveal mechanisms of MafA control. For example,
b-cell replication was produced by actions on cyclin
D2 regulation, while effects on granule docking af-
fected ﬁrst-phase insulin secretion. Moreover, nota-
ble differences in the genes regulated by embryonic
MafB and postnatal MafA gene expression were found.
These results not only clearly deﬁne why MafA is an
essential transcriptional regulator of islet b-cells, but
also why cell maturation involves coordinated actions
with MafB.
The pancreatic b-cell is one of several hormone-producing
cell types critical to glucose homeostasis present within
the islet of Langerhans. However, hyperglycemia is spe-
ciﬁcally caused by the loss or inability of b-cells to syn-
thesize and secrete the insulin hormone, causing diabetes
mellitus, a life-threating condition associated with mil-
lions of people worldwide. Current therapies for diabetes
involve external insulin treatment either through injec-
tion or a pump, but this still often results in long-term
medical complications, including cardiovascular disease,
chronic renal failure, and retinopathy. These complica-
tions are likely due to the inability of exogenously sup-
plied insulin to regulate blood glucose levels in the same
facile manner as endogenous b-cells. As a consequence,
efforts have been focused on understanding the molecular
mechanisms underlying normal b-cell development
and function, with the hope that such knowledge will
provide insight into therapeutic ways of either sustaining
endogenous b-cell function or engineering replacement
cells.
Genetic and biochemical studies have demonstrated
that islet-enriched transcription factors play a central role
in orchestrating the intricate series of events required in
the biosynthesis of islet hormone-producing a (i.e., glu-
cagon), b, d (somatostatin), ´ (ghrelin), and pancreatic
polypeptide cells (reviewed elsewhere [1–3]). The func-
tional signiﬁcance of these proteins was reinforced upon
observing that six of nine genes associated with a mono-
allelic form of diabetes, maturity-onset diabetes of the
young, encode for transcription factors essential to islet
cells (reviewed elsewhere [4,5]). Moreover, altering the
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expression of individual islet-enriched transcription fac-
tors often inﬂuences the presence and/or activity of a par-
ticular islet cell type (e.g., Arx [6], Pax4 [7], Pdx1
[maturity-onset diabetes of the young, type 4] [8]). In
addition, the combinatorial actions of these proteins are
capable of reprogramming nonislet cells to b-like cells,
exempliﬁed by misexpression of MafA, Pdx1, and Ngn3
in pancreatic acinar cells (9).
Interestingly, members of the same transcription
factor family often contribute to b-cell formation, includ-
ing winged-helix/forkhead-containing FoxA1 and FoxA2
(10), zinc ﬁnger Gata4 and Gata6 (11,12), NK6 homeo-
domain Nkx6.1 and Nkx6.2 (13), paired box homeodomain
Pax4 and Pax6 (7,14), as well as basic leucine-zipper MafA
and MafB (15). FoxA1/2, Nkx6.1/6.2, Gata4/6, and Pax4/6
are expressed broadly in early pancreatic epithelial cells
and then become principally conﬁned to islet cells (e.g.,
Nkx6.1 [b], FoxA1/A2 [all], Gata6 [all], Pax6 [all]) or cease
to be expressed after birth (Gata4, Pax4, Nkx6.2) (2,3).
However, MafA and MafB are distinct in being produced
relatively late during development and primarily (i.e.,
MafB [16]: a, b, Ngn3+ islet cell progenitors), if not ex-
clusively in hormone+ cells (b only, MafA [17]). Conse-
quently, analysis of Mafa and Mafb mutant mice has
revealed more specialized roles in islet cell maturation
than other islet-enriched transcription factors. Thus islet
cell identity and/or numbers are often profoundly af-
fected in islet-enriched transcription factor knockout
mice (1–3), whereas only terminal b- and a-cell matura-
tion is defective in Mafb2/2 embryos (16,18). In contrast,
islet cell development was unchanged in Mafa2/2 (19) or
pancreas-speciﬁc knockout MafaΔpanc (20) mice, although
glucose-regulated insulin secretion and islet cell architec-
ture was compromised in adults. Remarkably, human
embryonic-stem-derived insulin+ cells do not become glu-
cose responsive until the appearance of MafA (21,22),
with induction currently requiring transplantation of in
vitro programmed cells into mice (22).
Rodent b-cells switch from producing primarily MafB
during development to exclusively MafA postnatally
(18,20). Hence, MafB is expressed in all embryonic glu-
cagon+ cells and insulin+ cells produced during the ﬁrst
and secondary wave of hormone+ cell formation and then
disappears from b-cells roughly 2 weeks after birth
(16,18). In contrast, MafA is produced exclusively in the
second or principal wave of insulin+ cells arising from
embryonic (E) day 13.5 (17), which become the b-cells
of the islet. Notably, MafA controls many embryonically
activated MafB genes in adults (20). Here we have more
precisely deﬁned the functional interrelationship between
these closely related large Maf proteins by answering the
following questions: 1) When does MafA become impor-
tant to postnatal b-cells? 2) Is transient expression of
MafB postnatally signiﬁcant to islet b-cell activity? 3)
How does MafA regulate islet b-cells? 4) Are there genes
regulated by MafA in adults that are unaffected by MafB
during development?
A time course study performed with mice lacking MafA in
the pancreas (termed MafaΔpanc) revealed that loss of MafA
ﬁrst signiﬁcantly affected b-cell mass, b-cell function, and
islet architecture by 3 weeks of age. Large-Maf-regulated
gene expression in islet b-cells was compromised even earlier
in MafaΔpanc;Mafb+/2 than MafaΔpanc mice. Gene proﬁling
analysis revealed that MafA regulates many key aspects of
the glucose-stimulated insulin secretion pathway, including
glucose metabolism, insulin production, and insulin granule
docking. These ﬁndings substantially expand our knowledge
of how MafA affects islet b-cell activity and provide a greater
awareness into why this factor is so critical to the production
of functional b-cells.
RESEARCH DESIGN AND METHODS
Animals
Pancreas-wide MafA deletion mutant mice (MafaDpanc)
were generated by breeding Mafaﬂ/ﬂ with Pdx15.5-Cre
mice (20). Mafaﬂ/ﬂ mice served as experimental wild-
type controls. MafB+/2 mice have been described previ-
ously (20). CompoundMafaﬂ/ﬂ;Mafb+/2;Pdx15.5-Cre mutant
mice were referred to as MafaDpanc;Mafb+/2. All mice used
are on a mixed genetic background (C57BL/6J, I129,
Balb/c). The Vanderbilt University Institutional Animal
Care and Use Committee approved all of these studies.
Islet Isolation, RNA Extraction, and Quantitative Real-
Time PCR Analysis
Mice of 2, 3, or 4 weeks of age were anesthetized and then
killed via cervical dislocation. The abdominal cavity was
exposed and collagenase P (Roche) in PBS was injected
into the common bile duct with the end connecting to the
duodenum blocked. The pancreas was then isolated and
digested further with collagenase P and islets isolated by
hand picking under 103 magniﬁcation. Islet RNA was
isolated using TRIzol (Invitrogen) and further treated
with the DNA-Free RNA Kit (Zymo Research). RNA qual-
ity was determined using the Agilent 2100 Bioanalyzer in
the Vanderbilt Functional Genomics Shared Resource
Core Laboratory; RNA was only used if the integrity value
was 7 or greater. Quantitative real-time PCR (qPCR) was
conducted as previously described on a Light Cycler 480 II
(Roche) (20); primer sequences are available upon request.
The RNA data presented in Figs. 4 and 6 were performed
with islet preparations free of acinar cell contamination,
as determined by amylase analysis.
Tissue Preparation and Immunohistochemistry
The conditions used for parafﬁn embedding pancreatic
sections and immunoﬂuorescence labeling were described
previously (20). The following primary antibodies were
used for immunostaining: guinea pig a-insulin (1:2,000;
Linco Research), guinea pig a-glucagon (1:2,000; Linco
Research), rabbit a-glucagon (1:2,000; Linco Research),
rabbit a-MafB (1:10,000; Bethyl Laboratories), rabbit
a-MafA (1:1,000, Bethyl Laboratories), rabbit a-Slc30a8
(1:1,000, Mellitech), and rabbit a-Glut2 (1:1,000; Chemicon).
Species-matched secondary antibodies were used for
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Figure 1—MafA begins to affect b-cell gene expression by 3 weeks after birth. (A) The mRNA levels of MafA-regulated genes in 2- and
3-week-old MafaΔpanc and control islets. All were signiﬁcantly diminished by 3 weeks, with only Slc30a8 statistically changed at 2 weeks.
Results were presented as mean 6 SEM. *P < 0.05 (n $ 3); ***P < 0.001. (B) The 2- and 3-week-old Slc2a2 and Slc30a8 protein staining
pattern in wild-type and MafaΔpanc islets. The change in protein levels was most evident in 3-week-old MafaΔpanc b-cells. Representative
images are shown; nuclei were stained with Yopro1 (blue). The red channel (Slc2a2 or Slc30a8) was presented in gray scale next to each
ﬁgure. Scale bar = 20 mm.
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immune detection (Cy5-conjugated donkey anti–guinea
pig, Cy5-conjugated donkey anti-sheep, Cy2-conjugated
donkey anti–guinea pig, Cy2-conjugated donkey anti-
rabbit, Cy3-conjugated donkey anti-rabbit [all 1:500;
Jackson ImmunoResearch Laboratories]). Cy3-conjugated
tyramide signal ampliﬁcation (1:400, PerkinElmer) was
used for detecting MafB labeling with the biotin-conjugated
donkey anti-rabbit secondary antibody (1:500; Jackson
ImmunoResearch Laboratories). Nuclear counterstaining
was performed using YoPro1 or DAPI (Invitrogen). Im-
munoﬂuorescence images were acquired with a Carl Zeiss
LSM510 confocal microscope.
Islet Morphology, b- to a-Cell Ratio, and b-Cell Area
Analyses
Evenly spaced pancreatic sections at 150 and 240 mm
apart were used from 1- or 2- and 3-week-old mice, re-
spectively. Insulin+ cells and glucagon+ cell images were
counted at 4003 magniﬁcation. The b- to a-cell ratio was
calculated by dividing the total number of insulin+ cells by
the total number of glucagon+ cells. The relative b-cell
mass was determined in pancreatic sections where
insulin+ cells were visualized by DAB labeling, and pan-
creatic tissue was counterstained with eosin. Images of
pancreatic sections were captured at 203 magniﬁcation
using a ScanScope CS (Aperio), and the relative b-cell area
was calculated by dividing the area of insulin+ cells by that
of the whole pancreas.
Intraperitoneal Glucose Tolerance Test
Four-week-old mice (n $ 7) were fasted from 1800
to 0800 h, and blood glucose levels from the sampled
saphenous vein were determined using a FreeStyle
glucometer (Abbott Diabetes Care). The mice were then
weighed, and 1 mg dextrose/g body weight (FisherBiotech)
in sterile PBS was injected intraperitoneally. Blood glucose
levels were measured at 15, 30, 60, 90, and 120 min post-
injection. Fed blood glucose levels were measured prior to
fasting.
Islet Zn2+ Content
Freshly isolated islets were washed in Ca2+-free Hanks’
balanced salt solution and frozen at 280°C in size-
matched 20-islet aliquots. Islets were lysed in 1 mL lysis
buffer (1% Triton X-100 in 10 mmol/L Tris-HCl, pH = 7.4,
Figure 2—MafA inﬂuences b-cell proliferation. (A) Islet b-cell area is reduced in 3-week-oldMafaΔpanc mice when compared with littermate
wild-type mice (n = 3). *P < 0.05. No change in (B) b-cell apoptosis was detected in the TUNEL assay (n = 4; P = 0.8406), whereas the
percentage of (C) Ki67+ proliferating insulin+ cells decreased in 3-week-old MafaΔpanc islets (n = 4). *P < 0.05. Representative images of
Ki67 and insulin labeling were included in C. Approximately 3,000 insulin+ cells were counted per mouse in the Ki67 studies. Results were
presented as mean 6 SEM.
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made in double-distilled H2O [18.2 MV], avoiding any
glassware), and the Zn2+ concentration in the lysate was
measured using a FluoZin-3 (Invitrogen) ﬂuorescent dye
assay (23). The Zn2+ concentration per islet (micromoles
per islet) was determined by comparing the ﬂuorescent
signal at 516 nm to a standard curve generated from
serial dilutions of ZnCl2 in lysis buffer.
NAD(P)H Imaging
Freshly isolated islets were incubated in imaging me-
dium (125 mmol/L NaCl, 5.7 mmol/L KCl, 2.5 mmol/L
CaCl2, 1.2 mmol/L MgCl2, 10 mmol/L HEPES, 2 mmol/L
glucose, 0.1% BSA, pH = 7.4) for 90 min and placed in
a polydimethylsiloxane microﬂuidic ﬂow device (24) on
an LSM710 microscope (Zeiss). NAD(P)H autoﬂuores-
cence was imaged under two-photon excitation using
a 710 nm mode-locked Ti:sapphire laser oscillator (Coher-
ent) and a custom 380–500 nm band-pass ﬁlter (Chroma)
and nondescanned detector. Z-stacks of six images were
acquired at 2 mm spacing 10 min after a change in glucose
stimulation. All microscope and laser settings were kept
constant between measurements.
mRNA Microarray
Total isolated islet RNA was prepared from four independently
derived 3-month-old littermate MafaDpanc and wild-type mice.
Total RNA (50 ng) was ampliﬁed using the Ovation RNA
Ampliﬁcation System V2 (Nugen Inc.), labeled with the Bio-
Prime Array CGH Genomic Labeling System (Invitrogen Life
Technologies), puriﬁed, and then analyzed on the whole
mouse genome G4122A oligo microarray (Agilent Technology).
The microarray analysis was performed at the Functional
Genomics Core at the University of Pennsylvania.
Islet Perifusion
Islet function was studied in a dynamic cell perifusion
system at a perifusate ﬂow rate of 1 mL/min (25,26). The
efﬂuent was collected at 3-min intervals using an automatic
fraction collector. Insulin concentration in each fraction
was measured by radioimmunoassay (RI-13K, Millipore).
Insulin content in islet extracts was determined by radio-
immunoassay (insulin, RI-13K, Millipore).
Electron Microscopy
Islet b-cell ultrastructure was assessed by transmission
electron microscopy as described previously (25). The
density of b-cell secretory granules was determined using
Figure 3—The changes in islet architecture and glucose tolerance
in MafaDpanc mice are ﬁrst observed at 3 weeks, and these defects
appear more profound and earlier in MafaDpanc;Mafb+/2 mice.
(A, top) The glucagon+ and insulin+ staining pattern in 2- and
3-week-old wild-type, MafaDpanc, and MafaDpanc;Mafb+/2 pancreas.
Unlike wild-type, a-cells were commonly found in the islet core in
3-week-old MafaDpanc and MafaDpanc;Mafb+/2 mice. (A, bottom) In
addition, the b- to a-cell ratio is reduced in 3-week-old MafaΔpanc
mice and by 2 weeks in MafaDpanc;Mafb+/2 mice. (B, top) Impaired
glucose clearance was observed in 4-week-old MafaDpanc mice as
expected from the changes in islet architecture and b-cell gene
expression (Fig. 1A). Glucose intolerance is more severe in the
MafaDpanc;Mafb+/2 mutant of same age. (B, bottom) The area under
the curve of the glucose tolerance test curve is shown in the bar graph.
All data are presented as mean 6 SEM. *P < 0.05; **P < 0.01; ***P <
0.001 compared with wild-type control. ##P< 0.01; ###P< 0.001
compared with MafaDpanc. AUC, area under the curve.
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Figure 4—MafA regulates both insulin content and glucose-stimulated insulin secretion levels. (A) Dynamic glucose-regulated insulin
secretory characteristics of perifused 12-week-old MafaΔpanc, MafaΔpanc;Mafb+/2, and control islets (MafaΔpanc, n = 5; MafaΔpanc;Mafb+/2,
n = 5; wild-type, n = 4). (B) Integrated area under the curve showed that the ﬁrst phase of glucose-stimulated insulin secretion was
decreased by 79% in MafaΔpanc versus the control (***P < 0.0001), with only second-phase secretion trending lower (P = 0.1319). Similarly,
only ﬁrst-phase insulin secretion was impaired in MafaΔpanc;Mafb+/2 mutant islets (45% of wild-type). **P < 0.001; ***P < 0.001. (C) Islet
insulin content in 12-week-oldMafaΔpancmice was down by 37% andMafaΔpanc;Mafb+/2 by 47% when compared with controls. **P< 0.01.
(D) Critical regulators of insulin secretion pathway were compromised in adult MafaDpanc and MafaΔpanc;Mafb+/2 mouse islets, including
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MetaMorph v7.7 software (Universal Imaging, Downing-
ton, PA) of calibrated images captured at 5,6003 magni-
ﬁcation. The number of docked b-cell granules was
expressed per membrane length and b-cell granule size
measured using ImageScope software (Aperio, Vista, CA)
of calibrated images captured at 5,6003. The granule size
was measured using ImageScope software of calibrated
images captured at 25,0003 magniﬁcation. Each analysis
was based on 12–15 images per genotype.
Quantiﬁcation and Statistical Analysis
All data were presented as mean6 SEM, and mean differ-
ences were tested for statistical signiﬁcance using the
Student two-tail t test unless otherwise noted.
RESULTS
Impact of MafA Loss on b-Cell Function, b-Cell Mass,
and Islet Architecture Is not Observed Until 3 Weeks of
Age
Genes important to b-cell function are regulated by MafB at
E18.5 and by MafA in 3-month-old islets, including those
involved in glucose sensing (i.e., Slc2a2), vesicle maturation
(Slc30a8), Ca2+ signaling (Camk2b), and glucose metabolism
(G6pc2) (20). To more precisely deﬁne the postnatal period
when MafA becomes essential for regulating b-cells, a time
course study was performed. Quantitative PCR analysis
revealed that Insulin 1 (Ins1), Insulin 2 (Ins2), Slc2a2,
G6pc2, and Slc30a8 mRNA expression levels were reduced
in 3-week-old MafaDpanc islets (Fig. 1A), with only Slc30a8
signiﬁcantly reduced within 2 weeks. Notably, MafB is
barely detectable in 2-week-old b-cells (20). In addition,
there were clearly fewer insulin+ cells producing the
Slc2a2 and Slc30a8 proteins in 3-week-old MafaDpanc islets
(Fig. 1B), which, respectively, represent the glucose and zinc
transporters required for normal b-cell function (27–29).
The number of islet b-cells was also diminished in 3-week-
old MafaDpanc islets (Fig. 2), whereas the glucagon+ a-cell
population was unchanged (Supplementary Fig. 1). Notably,
this resulted from diminished b-cell replication and not
increased apoptosis (Fig. 2B and C).
The presence of a-cells within the islet b-cell-enriched
core is commonly observed in pancreatic transcription
factor-deﬁcient mice (e.g., Pdx1 [30,31] and Pax6 [14]).
Conspicuously, MafA (but not MafB) expression is com-
promised in many, if not all, of these mutants (e.g., Pdx1
[32], Pax6 [33], data not shown). The previously ob-
served intermingling of glucagon+ a-cells within the
b-cell enriched islet core (19) was also regulated within
the 3-week temporal period in MafaDpanc islets, as was
the decrease in the islet insulin+ to glucagon+ cell ratio
(Fig. 3A). Furthermore, glucose clearance was impaired
in 4-week-old MafaDpanc mice (Fig. 3B). Collectively, these
data highlighted how indispensable MafA is in postnatal
islet b-cells after the loss of MafB expression.
Islet Morphology and Glucose Clearance Are Impaired
Earlier in Compound MafaDpanc;Mafb+/2 Mice
Unfortunately, the functional signiﬁcance of MafB in
neonatal b-cells remains unknown since Mafb2/2 mice
die at birth from central apnea (34). To obtain a greater
awareness of MafB actions during this period, changes in
islet morphology and function were compared between
MafaDpanc;Mafb+/2 and MafaDpanc littermates. The reduc-
tion in the b- to a-cell ratio started 2 weeks after birth
granule docking (Sytl4), vesicle exocytosis (Stxbp1), and calcium transport (Atp2a2). The mRNA levels were measured by qPCR in
MafaDpanc, MafaΔpanc;Mafb+/2, and wild-type islets (n = 3). **P < 0.01; ***P < 0.0001. (E ) Representative electron micrographs of a
12-week-old MafaΔpanc and wild-type b-cell. (F) Insulin granule size (n $ 320 granules/genotype), granule density (n $ 64 b-cells/genotype),
and number of docked granules (n $ 41 b-cells/genotype) are reduced in MafaΔpanc b-cells. **P < 0.01; ***P < 0.0001. AUC, area under the
curve; G, glucose; IEQ, islet equivalent.
Figure 5—Zn2+ and NAD(P)H content in MafaΔpanc and MafaΔpanc;
Mafb+/2 b-cells. (A) Total islet Zn+2 content was reduced to 56% in
3-month-old MafaΔpanc islets and 37% in MafaΔpanc;Mafb+/2 islets
(wild-type, n = 10; MafaΔpanc, n = 9; MafaΔpanc;Mafb+/2, n = 5). *P <
0.05; **P < 0.01. (B) Normalized glucose dose-response curve of
NAD(P)H levels in 3-month-old wild-type, MafaΔpanc, and MafaΔpanc;
Mafb+/2 islets (n = 4). The NAD(P)H response was not signiﬁcantly
different from base line until 20 mmol/L glucose. *P < 0.05, inde-
pendent samples. arb., arbitrary.
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Figure 6—Gene set enrichment analysis reveals MafA regulation of many key b-cell activities. (A) The mRNA expression levels of 13 MafA
microarray identiﬁed candidate genes in 3-week-oldMafaΔpanc and control islets (n$ 3). *P< 0.05; **P< 0.01; ***P< 0.001. Gene ontology
analysis showing the (B) cellular component and (C) molecular function enrichment obtained from the microarray mRNA studies performed
on 3-month-old wild-type andMafaΔpanc islets. Each pie chart section is proportional to the number of genes in the category. The acinar cell
signals in the MafaΔpanc microarray data are contamination, since these were not detected in the independently isolated MafaΔpanc islet
preparations used for Figs. 4 and 6. (D) Signaling pathway impact analysis illustrates those signiﬁcantly altered inMafaΔpanc islets. Each dot
represents a unique signaling pathway, with those labeled with an identiﬁcation number most signiﬁcantly perturbed. A red dot denotes
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in MafaDpanc;Mafb+/2 islets, 1 week earlier than the
MafaDpanc mutant (Fig. 3A). Such changes were not ob-
served at any postnatal time point in Mafb+/2 islets
(data not shown). Additionally, MafaDpanc;Mafb+/2 mice
displayed more profound defects in acute glucose clear-
ance (Fig. 3B). Taken together, these data indicate a role
for MafB in postnatal b-cell maturation.
First-Phase Insulin Secretion, Insulin Granule Density,
and the Number of Docked Insulin Granules Are
Regulated by MafA and MafB in Islets
Because blood glucose clearance was compromised after
an intraperitoneal glucose challenge in MafaDpanc mice
(20), islet perifusion assays were performed to deter-
mine whether this resulted from an effect on ﬁrst- and/
or second-phase insulin granule release. In relation to
wild-type littermates, ﬁrst-phase insulin secretion was
signiﬁcantly reduced in MafaDpanc islets, with second-
phase trending in this direction (Fig. 4A and B). Islet in-
sulin content was also decreased by ;40% in MafaDpanc
b-cells (Fig. 4C). Analogous ﬁndings were also observed in
MafaDpanc;Mafb+/2 islets.
Given that biphasic insulin secretion reﬂects the
recruitment and release of geographically distinct pools
of insulin-containing granules, the ultrastructure appear-
ance of control and MafaDpanc b-cells were compared by
transmission electron microscopy. MafaDpanc b-cells con-
tained 40% less mature insulin granules with a character-
istic dark core appearance (Fig. 4E). Granule density and
size was also reduced to a similar extent (Fig. 4F). More-
over, the number of docked insulin granules that are exo-
cytosed during the ﬁrst phase of glucose-stimulated
insulin secretion was decreased by 55% in MafaDpanc
b-cells. A similar deﬁciency in mature insulin granule for-
mation was found in Slc30a82/2 islets (35), circumstances
that preclude Zn2+ transport into granules for insulin
crystallization and the dense-core appearance. Both
Slc30a8 expression (Fig. 1B) and Zn2+ levels (Fig. 5A)
were also signiﬁcantly reduced in MafaDpanc and
MafaDpanc;Mafb+/2 b-cells, with the compound mutant be-
ing effected more dramatically. In contrast, NAD(P)H-
sensitive metabolic activity in MafaDpanc and MafaDpanc;
Mafb+/2 islets was not impaired until high glucose con-
centrations (Fig. 5B). These data support a role for MafA
in regulating processes directly involved in insulin synthe-
sis, storage, and secretion.
MafA Impacts Genes Involved in Many Aspects of Islet
b-Cell Function
To obtain an unbiased and comprehensive perspective on
MafA control in mouse islets, Affymetrix whole mouse
genome proﬁling was performed on isolated 3-month-old
MafaDpanc and control islets. There was a signiﬁcant dif-
ference in 1,093 array transcripts in the MafaDpanc sample
(with a false discovery rate of 10% and a fold change .2),
with 741 of these mapped to distinct EntrezGene identi-
ﬁers (Supplementary Table 1). However, there were sev-
eral exocrine-enriched genes within the differentially
expressed group (e.g., elastase, carboxypeptidase, chymo-
trypsinogen), indicating possible contamination of the is-
let RNA preparation. This was veriﬁed by analyzing
expression for exocrine marker gene levels in other in-
dependently isolated MafaDpanc RNA samples (data not
shown). Consequentially, 13 candidate genes were se-
lected from the microarray to determine the accuracy
of the data. Importantly, qPCR studies performed on
3-week-old islet RNAs conﬁrmed the same changes be-
tween wild-type and MafaDpanc (Fig. 6A), with 11 genes
altered signiﬁcantly in the expected manner and 2 show-
ing the same trend. These results indicate that much of
the microarray data reﬂects MafA control of islet b-cell
gene expression. This included cyclin D2 (i.e., Ccdn2),
a primary cell cycle regulator in islets (36), contributing
to the decrease in MafaDpanc b-cell mass (Fig. 2). Notably,
these results also revealed early control by MafA in post-
natal b-cells, suggesting that MafA is inﬂuencing tran-
scription directly.
Gene ontology enrichment analysis performed on the
MafaDpanc and control islet microarray data disclosed that
protein-binding and ion-binding activity were affected
most profoundly, although MafA appears to inﬂuence
a broad range of cellular functions found in many distinct
subcellular compartments (Fig. 6B and C). Importantly,
established effectors of granule docking (Sytl4, granuphi-
lin [37]), granule release (Stxbp1, Munc18–1 [38]), and
calcium inﬂux (Atp2a2 [39,40]) were identiﬁed (Supple-
mentary Table 1), with regulation conﬁrmed by qPCR (Fig.
4). When these data are also considered in the context of
the decrease in Ins1, Ins2, Slc30a8, Slc2a2 (the major b-cell
GLUT [27]), and G6pc2 (a key gluconeogenic enzyme [41])
levels in MafaDpanc islet b-cells (Fig. 1), these combined
deﬁciencies provide an explanation as to why the ﬁrst
phase of glucose-stimulated insulin secretion was partic-
ularly impaired.
Interestingly, while many genes appear to be commonly
regulated by MafA and MafB (20), expression-proﬁling
analyses identiﬁed genes only affected in 3-month-old
MafaDpanc islets and not E18.5 Mafb2/2 pancreata (e.g.,
Ccnd2, Nqo1, and Atp2a2). Moreover, pathway analysis
further supported MafA control in many aspects of
b-cell signaling, including those involved with the extra-
cellular matrix receptor (see 4512), chemokines (4062),
a signiﬁcance of P < 0.05 after Bonferroni correction and blue P < 0.05 after false discovery rate correction. ECM, extracellular matrix; GO,
gene ontology; MAPK, mitogen-activated protein kinase; P NDE, probability of number of differentially expressed genes; P PERT, prob-
ability of perturbation; SPIA, signaling pathway impact analysis; TGF, transforming growth factor.
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focal adhesion (4510), cytokine–cytokine receptor (4060),
and mitogen-activated protein kinase signaling (4010).
(The numbers in the parentheses refer to pathways de-
scribed in Fig. 6, Supplementary Fig. 2, and Supplemen-
tary Table 2.) Collectively, these gene expression studies
provide a broader perspective into the many modes of
action used by MafA to regulate b-cell function.
DISCUSSION
Our principal objective here was to precisely deﬁne when
MafA ﬁrst became functionally signiﬁcant to mouse
b-cells postnatally and to explore the nature of the de-
pendency. Experiments performed in MafaDpanc mice
revealed that MafA was important to b-cells from 3 weeks
of age, just after their loss of MafB. This included changes
in b-cell mass, islet cell architecture, and glucose-
stimulated insulin secretion. The proteins likely mediating
these changes were identiﬁed by candidate and microar-
ray analysis. These studies provide an in-depth perspec-
tive into the many ways MafA inﬂuences islet b-cells and
mechanistic insight into why it is so necessary in cell
maturation and adult activity.
MafA only begins to inﬂuence b-cells around weaning
time in laboratory rodents. The switch from high-fat-
based mother’s milk to a chow diet results in higher MafA
expression and signiﬁcant changes in the metabolic pro-
ﬁle of rodent b-cells (42). Notably, MafB+ neonatal b-cells
were functional immature, characterized by higher basal
insulin secretion and little response to glucose. The MafB-
to-MafA transition appears to be key to b-cell maturation.
This is illustrated not only by the islet b-cell deﬁciencies
of Mafa2/2 and MafaDpanc mice, but also from studies
examining the glucose-sensitive regulatory properties of
in vitro generated insulin+ cells derived during human
embryonic stem differentiation (21,22,43). Thus these
Ins+ cells are only MafB+ and do not secrete insulin in
a glucose-stimulated manner until after transplantation
into mice, when the cells become MafA+ (22). The present
studies predict many likely inadequacies in the human
embryonic stem–derived MafB+ Ins+ cells due to their
lack of MafA, including diminished expression of key
effectors of insulin granule secretion (Stxbp1, Sytl4), cal-
cium signaling (Atp2a2), and glucose signaling (G6pc2,
Slc2a2).
MafA has a clear effect on insulin granule release.
Hence glucose-stimulated insulin secretion, insulin gran-
ule density, and the number of predocked insulin
granules on the plasma membrane were decreased in
MafaDpanc b-cells (Fig. 4). The reduction in the total
number and size of mature dense-core insulin granules
per cell is presumably attributable to diminished produc-
tion of both insulin and the Slc30a8 zinc transporter
(Figs. 1 and 4). Despite an ;30% paucity of insulin
granules in MafaDpanc b-cells, there was a .50% loss
predocked granules. Consistent with the concept that
predocked granule release supports ﬁrst-phase insulin
secretion, MafaDpanc b-cells were only signiﬁcantly
decreased during this phase. Presumably, this was due
to limited expression of key MafA-regulated docking
effectors (e.g., granuphilin [Sytl4] and Munc18–1
[Stxbp1]). Importantly, Munc18–1 was recently found
to speciﬁcally regulate ﬁrst-phase insulin secretion (38).
The architecture of the MafaDpanc islet is similar to
human (44), with fewer b-cells and a-cells present within
the core (Fig. 3). The reduced number of b-cells in
MafaDpanc islets reﬂected a change in replication and not
cell survival, likely involving cyclin D2. Potentially, the
coexpression of MAFA and MAFB in human islets (26)
contributes to the difference in islet architecture and
b-cell composition between species. This is supported by
the lack of any observable change in endocrine cell num-
bers, replication rate, or cyclin D2 levels in the embryonic
Mafb2/2 pancreas (16) (data not shown). On the other
hand, adult MafA controls many genes activated by MafB
during mouse embryonic development (20). The more
severe defects of the compound MafaDpanc:Mafb+/2 mu-
tant relative to MafaDpanc further indicates that MafB is
also beneﬁcial to b-cells prior to its loss postnatally.
The overall mechanistic similarities and differences
between MafA and MafB are still unclear. Notably, only
35 genes were identiﬁed in the PancChip 6 microarray
performed on E18.5 Mafb2/2 pancreata (i.e., $1.5-fold;
47 in MafaDpanc;Mafb2/2; none in MafaDpanc [20]), while
741 mapped to EntrezGene identiﬁers using the Affyme-
trix platform on 3-month-old MafaDpanc islets here. Much
of the difference is likely due to the relative insensitivity
of the PancChip 6 microarray. It is expected that reinspec-
tion of Mafb2/2 pancreata will reveal both common and
distinct regulatory targets in relation to the Mafa mutant,
especially considering that MafaDpanc b-cells are dysfunc-
tional despite the presence of many MafB+ Ins+ cells (20).
Both biochemical and cell-line-based studies also provide
evidence supporting functional differences between islet
cell expressed MafA and MafB (15,45,46). Consequen-
tially, human MAFA:MAFB heterodimer activity in islet
b-cells may contribute to observed differences in glucose-
stimulated insulin secretion properties with rodents (26).
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